1318 (1318) Fair Value & Analysis

Consumer Defensive · Market cap HK$27.0B

1 1318 1318 · HK

PriceHK$51.85

Fair ValueHK$57.26

Upside+10.4%

Quality53/100

Evidence: High Range HK$44.35 – HK$142.01

Fair value as of: Jul 2, 2026

From 26 valuation models · updated today

Share price −13.4% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$50.60 – HK$109.67 · fair‑value band HK$44.35 – HK$142.01 · the HK$51.85 price screens below the HK$57.26 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1318 (1318) currently trades at HK$51.85, while our model-based Fair Value estimate is HK$57.26 — implying the stock looks roughly 10.4% undervalued today. We read business quality at 53/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 1318 generated revenue of HK$5.1B at a net margin of 23.8%. Revenue grew 28.7% year over year. It earns a return on equity of 29.5%. The stock trades on a trailing P/E of 19.4. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$5.1B

Revenue growth (YoY) +28.7%

Net margin 23.8%

Return on equity 29.5%

Free cash flow HK$1.0B FY2025

P/E ratio 19.4

More key figures

Operating margin 26.4%

EPS (TTM) HK$1.37

Dividend yield 1.9%

EPS growth (YoY) +71.0%

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1318 reported revenue of HK$5.1B in FY2025 versus HK$1.6B in FY2021, a compound +33.8%/yr. Reported net income was HK$1.2B in FY2025, compounding +38.1%/yr from FY2021.

Revenue +33.8%/yr

FY21 HK$1.6B

FY22 HK$1.8B

FY23 HK$2.9B

FY24 HK$3.9B

FY25 HK$5.1B

Net income +38.1%/yr

FY21 HK$331M

FY22 HK$352M

FY23 HK$662M

FY24 HK$881M

FY25 HK$1.2B

Is 1318 fairly valued? → Check now

Similar stocks

6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
PG PG	2,590 MXN	1,732 MXN	-33%
The Procter & Gamble Company PGCO34	R$55.00	R$36.15	-34%
L'Oréal S.A LRLCF	$450.56	$209.17	-54%
Unilever PLC UNLYF	$59.34	$46.11	-22%
Colgate-Palmolive Company CPA	€79.98	€55.96	-30%
Hindustan Unilever Limited HINDUNILVR	₹2,170	₹807.38	-63%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1318 (1318) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$57.26 versus a price of HK$51.85 — about +10% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1318?

Our model-based fair value for 1318 is HK$57.26 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$51.85.

What is the quality score of 1318?

1318 has a Quality Score of 53/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1318 (1318)?

1318 reported trailing-twelve-month revenue of about HK$5.1B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1318?

The net profit margin of 1318 is about 23.8%, meaning it keeps roughly 23.8% of revenue as net income. Based on the latest reported figures.

Does 1318 pay a dividend?

1318 currently shows a dividend yield of about 1.93% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.